These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 20362664)

  • 1. RGS2 inhibits beta-adrenergic receptor-induced cardiomyocyte hypertrophy.
    Nunn C; Zou MX; Sobiesiak AJ; Roy AA; Kirshenbaum LA; Chidiac P
    Cell Signal; 2010 Aug; 22(8):1231-9. PubMed ID: 20362664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RGS2 is upregulated by and attenuates the hypertrophic effect of alpha1-adrenergic activation in cultured ventricular myocytes.
    Zou MX; Roy AA; Zhao Q; Kirshenbaum LA; Karmazyn M; Chidiac P
    Cell Signal; 2006 Oct; 18(10):1655-63. PubMed ID: 16517124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of cardiomyocyte signaling by RGS proteins: differential selectivity towards G proteins and susceptibility to regulation.
    Hao J; Michalek C; Zhang W; Zhu M; Xu X; Mende U
    J Mol Cell Cardiol; 2006 Jul; 41(1):51-61. PubMed ID: 16756988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new regulation of IL-6 production in adult cardiomyocytes by beta-adrenergic and IL-1 beta receptors and induction of cellular hypertrophy by IL-6 trans-signalling.
    Szabo-Fresnais N; Lefebvre F; Germain A; Fischmeister R; Pomérance M
    Cell Signal; 2010 Jul; 22(7):1143-52. PubMed ID: 20227492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inducible cAMP early repressor (ICER) is a negative-feedback regulator of cardiac hypertrophy and an important mediator of cardiac myocyte apoptosis in response to beta-adrenergic receptor stimulation.
    Tomita H; Nazmy M; Kajimoto K; Yehia G; Molina CA; Sadoshima J
    Circ Res; 2003 Jul; 93(1):12-22. PubMed ID: 12791704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenovirus-mediated overexpression of diacylglycerol kinase-zeta inhibits endothelin-1-induced cardiomyocyte hypertrophy.
    Takahashi H; Takeishi Y; Seidler T; Arimoto T; Akiyama H; Hozumi Y; Koyama Y; Shishido T; Tsunoda Y; Niizeki T; Nozaki N; Abe J; Hasenfuss G; Goto K; Kubota I
    Circulation; 2005 Mar; 111(12):1510-6. PubMed ID: 15781737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II-evoked enhanced expression of RGS2 attenuates Gi-mediated adenylyl cyclase signaling in A10 cells.
    Li Y; Hashim S; Anand-Srivastava MB
    Cardiovasc Res; 2005 Jun; 66(3):503-11. PubMed ID: 15914115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective loss of fine tuning of Gq/11 signaling by RGS2 protein exacerbates cardiomyocyte hypertrophy.
    Zhang W; Anger T; Su J; Hao J; Xu X; Zhu M; Gach A; Cui L; Liao R; Mende U
    J Biol Chem; 2006 Mar; 281(9):5811-20. PubMed ID: 16380388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SHP2 mediates gp130-dependent cardiomyocyte hypertrophy via negative regulation of skeletal alpha-actin gene.
    Nakaoka Y; Shioyama W; Kunimoto S; Arita Y; Higuchi K; Yamamoto K; Fujio Y; Nishida K; Kuroda T; Hirota H; Yamauchi-Takihara K; Hirano T; Komuro I; Mochizuki N
    J Mol Cell Cardiol; 2010 Aug; 49(2):157-64. PubMed ID: 20226789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone-releasing hormone promotes survival of cardiac myocytes in vitro and protects against ischaemia-reperfusion injury in rat heart.
    Granata R; Trovato L; Gallo MP; Destefanis S; Settanni F; Scarlatti F; Brero A; Ramella R; Volante M; Isgaard J; Levi R; Papotti M; Alloatti G; Ghigo E
    Cardiovasc Res; 2009 Jul; 83(2):303-12. PubMed ID: 19293247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RGS2 interacts with Gs and adenylyl cyclase in living cells.
    Roy AA; Baragli A; Bernstein LS; Hepler JR; Hébert TE; Chidiac P
    Cell Signal; 2006 Mar; 18(3):336-48. PubMed ID: 16095880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of receptor-selective effects of either RGS2, RGS3 or RGS4 on muscarinic M3- and gonadotropin-releasing hormone receptor-mediated signalling through G alpha q/11.
    Karakoula A; Tovey SC; Brighton PJ; Willars GB
    Eur J Pharmacol; 2008 Jun; 587(1-3):16-24. PubMed ID: 18457830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. beta-Adrenergic stimulation of rat cardiac fibroblasts promotes protein synthesis via the activation of phosphatidylinositol 3-kinase.
    Colombo F; Noël J; Mayers P; Mercier I; Calderone A
    J Mol Cell Cardiol; 2001 Jun; 33(6):1091-106. PubMed ID: 11444915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective enhancement of beta-adrenergic receptor signaling by overexpression of adenylyl cyclase type 6: colocalization of receptor and adenylyl cyclase in caveolae of cardiac myocytes.
    Ostrom RS; Violin JD; Coleman S; Insel PA
    Mol Pharmacol; 2000 May; 57(5):1075-9. PubMed ID: 10779394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelin-1-induced cardiac hypertrophy is inhibited by activation of peroxisome proliferator-activated receptor-alpha partly via blockade of c-Jun NH2-terminal kinase pathway.
    Irukayama-Tomobe Y; Miyauchi T; Sakai S; Kasuya Y; Ogata T; Takanashi M; Iemitsu M; Sudo T; Goto K; Yamaguchi I
    Circulation; 2004 Feb; 109(7):904-10. PubMed ID: 14967736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. cAMP-mediated beta-adrenergic signaling negatively regulates Gq-coupled receptor-mediated fetal gene response in cardiomyocytes.
    Patrizio M; Vago V; Musumeci M; Fecchi K; Sposi NM; Mattei E; Catalano L; Stati T; Marano G
    J Mol Cell Cardiol; 2008 Dec; 45(6):761-9. PubMed ID: 18851973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ontogeny of regulatory mechanisms for beta-adrenoceptor control of rat cardiac adenylyl cyclase: targeting of G-proteins and the cyclase catalytic subunit.
    Zeiders JL; Seidler FJ; Slotkin TA
    J Mol Cell Cardiol; 1997 Feb; 29(2):603-15. PubMed ID: 9140819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin II induced upregulation of G alpha q/11, phospholipase C beta 3 and extracellular signal-regulated kinase 1/2 via angiotensin II type 1 receptor.
    Bai H; Wu LL; Xing DQ; Liu J; Zhao YL
    Chin Med J (Engl); 2004 Jan; 117(1):88-93. PubMed ID: 14733781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct beta-adrenergic receptor subtype signaling in the heart and their pathophysiological relevance.
    Zheng M; Han QD; Xiao RP
    Sheng Li Xue Bao; 2004 Feb; 56(1):1-15. PubMed ID: 14985822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RGS2 is a primary terminator of β₂-adrenergic receptor-mediated G(i) signaling.
    Chakir K; Zhu W; Tsang S; Woo AY; Yang D; Wang X; Zeng X; Rhee MH; Mende U; Koitabashi N; Takimoto E; Blumer KJ; Lakatta EG; Kass DA; Xiao RP
    J Mol Cell Cardiol; 2011 Jun; 50(6):1000-7. PubMed ID: 21291891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.